These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1992151)

  • 1. Design of a well-absorbed renin inhibitor.
    Rosenberg SH; Kleinert HD; Stein HH; Martin DL; Chekal MA; Cohen J; Egan DA; Tricarico KA; Baker WR
    J Med Chem; 1991 Jan; 34(1):469-71. PubMed ID: 1992151
    [No Abstract]   [Full Text] [Related]  

  • 2. Water-soluble renin inhibitors: design of a subnanomolar inhibitor with a prolonged duration of action.
    Rosenberg SH; Woods KW; Sham HL; Kleinert HD; Martin DL; Stein H; Cohen J; Egan DA; Bopp B; Merits I
    J Med Chem; 1990 Jul; 33(7):1962-9. PubMed ID: 2194033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New modified heterocyclic phenylalanine derivatives. Incorporation into potent inhibitors of human renin.
    Ocain TD; Deininger DD; Russo R; Senko NA; Katz A; Kitzen JM; Mitchell R; Oshiro G; Russo A; Stupienski R
    J Med Chem; 1992 Mar; 35(5):823-32. PubMed ID: 1548674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
    Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
    J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
    Thaisrivongs S; Pals DT; Harris DW; Kati WM; Turner SR
    J Med Chem; 1986 Oct; 29(10):2088-93. PubMed ID: 3531518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacodynamic study of the renin inhibitor SR 43,845, administered intratracheally in conscious cynomolgus monkeys.
    Lacour C; Roccon A; Cazaubon C; Richaud JP; Segondy D; Nisato D
    J Hypertens Suppl; 1991 Dec; 9(6):S384-5. PubMed ID: 1819002
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors.
    Imaeda Y; Tawada M; Suzuki S; Tomimoto M; Kondo M; Tarui N; Sanada T; Kanagawa R; Snell G; Behnke CA; Kubo K; Kuroita T
    Bioorg Med Chem; 2016 Nov; 24(22):5771-5780. PubMed ID: 27687967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.
    Patt WC; Hamilton HW; Taylor MD; Ryan MJ; Taylor DG; Connolly CJ; Doherty AM; Klutchko SR; Sircar I; Steinbaugh BA
    J Med Chem; 1992 Jul; 35(14):2562-72. PubMed ID: 1635057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: discovery of DS-8108b, an orally active renin inhibitor.
    Nakamura Y; Fujimoto T; Ogawa Y; Namiki H; Suzuki S; Asano M; Sugita C; Mochizuki A; Miyazaki S; Tamaki K; Nagai Y; Inoue S; Nagayama T; Kato M; Chiba K; Takasuna K; Nishi T
    Bioorg Med Chem; 2013 Jun; 21(11):3175-96. PubMed ID: 23598247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
    Raddatz P; Jonczyk A; Minck KO; Schmitges CJ; Sombroek J
    J Med Chem; 1991 Nov; 34(11):3267-80. PubMed ID: 1956045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR; Hui KY; Coletti C; Hollenberg NK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of amino heterocycle aspartyl protease inhibitors.
    Chambers RK; Khan TA; Olsen DB; Sleebs BE
    Org Biomol Chem; 2016 Jun; 14(22):4970-85. PubMed ID: 27143279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
    Chen A; Aspiotis R; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Han Y; Houle R; Laliberté S; Larouche G; Lévesque JF; McKay D; Percival D
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7399-404. PubMed ID: 22071301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin inhibitors containing alpha-heteroatom amino acids as P2 residues.
    Repine JT; Kaltenbronn JS; Doherty AM; Hamby JM; Himmelsbach RJ; Kornberg BE; Taylor MD; Lunney EA; Humblet C; Rapundalo ST
    J Med Chem; 1992 Mar; 35(6):1032-42. PubMed ID: 1552498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.
    Ostermann N; Ruedisser S; Ehrhardt C; Breitenstein W; Marzinzik A; Jacoby E; Vangrevelinghe E; Ottl J; Klumpp M; Hartwieg JC; Cumin F; Hassiepen U; Trappe J; Sedrani R; Geisse S; Gerhartz B; Richert P; Francotte E; Wagner T; Krömer M; Kosaka T; Webb RL; Rigel DF; Maibaum J; Baeschlin DK
    J Med Chem; 2013 Mar; 56(6):2196-206. PubMed ID: 23360239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of inhibitors of human renin with high oral bioavailability.
    Hoover DJ; Lefker BA; Rosati RL; Wester RT; Kleinman EF; Bindra JS; Holt WF; Murphy WR; Mangiapane ML; Hockel GM
    Adv Exp Med Biol; 1995; 362():167-80. PubMed ID: 8540316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Hydroxy phosphinyl-based inhibitors of human renin.
    Patel DV; Rielly-Gauvin K; Ryono DE; Free CA; Rogers WL; Smith SA; DeForrest JM; Oehl RS; Petrillo EW
    J Med Chem; 1995 Oct; 38(22):4557-69. PubMed ID: 7473584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical synthesis of a renin inhibitor via a diastereoselective Dieckmann cyclization.
    Gauvreau D; Hughes GJ; Lau SY; McKay DJ; O'Shea PD; Sidler RR; Yu B; Davies IW
    Org Lett; 2010 Nov; 12(22):5146-9. PubMed ID: 20945851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.